Probiotics have been extensively studied in atopic dermatitis. The relationship between the gut microbiome and skin inflammation gives probiotics a plausible mechanism. The evidence, however, is more nuanced than the enthusiasm in popular media suggests.
The Biological Case for Probiotics in Eczema
- Infants with atopic dermatitis have reduced gut microbiome diversity
- Early antibiotic exposure, which disrupts colonization, increases atopic disease risk
- Specific bacteria (Lactobacillus and Bifidobacterium) are reduced in eczema patients
- Germ-free animal models develop more severe allergic skin inflammation
What the Clinical Evidence Shows
Prevention (best evidence): The strongest evidence is in prevention, not treatment. Well-designed trials have found that probiotic supplementation during pregnancy and early infancy reduces the risk of atopic dermatitis developing in high-risk children. The World Allergy Organization conditionally recommends probiotic use for pregnant women and infants at high risk of atopic disease.
Treatment of established eczema (weaker evidence): For treating existing atopic dermatitis, clinical trials are less convincing. Some individual trials show modest reductions in eczema scores. Meta-analyses generally find small effects that may not be clinically meaningful.
Which Probiotics?
Not all probiotics are equivalent. Lactobacillus rhamnosus GG (LGG) and various Bifidobacterium strains have the most evidence in atopic dermatitis specifically. The strain, dose, and duration matter significantly.
Practical Takeaways
- Probiotics are safe and reasonable to try for eczema patients
- Do not expect dramatic improvement
- For high-risk pregnant women or infants, there is genuine preventive evidence
- Quality matters, use a refrigerated, high-CFU product with identified strains
For comprehensive eczema treatment, see NuLine’s active atopic dermatitis studies.